Urgent.News

What's breaking now, across thousands of outlets.

Business

Telix Pharmaceuticals to acquire and merge with BlackRock-backed ITM for up to $2.35bn

Telix will pay $1.65 billion in cash upfront for 100 percent of ITM's shares, plus up to $700 million in contingency payments. The post Telix Pharmaceuticals to acquire and merge with BlackRock-backed ITM for up to $2.35bn appeared first on PE Hub .

We haven't written up this one. PE Hub has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Read the original at pehub.com →

More in Business

More from Monday 21 September →